The application of nanomaterials in the diagnosis, prevention, and treatment of viral diseases is reviewed in detail, highlighting areas of significant progress or stagnation from the past few decades.
Get Started for FREE
Sign up with Facebook Sign up with X
I don't have a Facebook or a X account
![]() ![]() |
Therapeutic nanosystems and diagnostic systems are increasingly being applied to various areas of medicine, acting as sensors, delivery vehicles, immunostimulants, radiation sensitizers and viral inhibitors. In an article recently published in the journal Pharmaceutics, the application of nanomaterials in the diagnosis, prevention and treatment of viral diseases is reviewed in detail, highlighting areas of significant progress or stagnation over the past decades. Drug delivery is the primary focus of nanomaterials in disease treatment, generally offering improved pharmacokinetics, drug retention time, and "drug-like" of the administered compound. The physical and chemical properties of the nanoparticle strongly influence the biodistribution of the nanomedicine in the body and the ability and propensity of the particle to enter the target cells. In addition to being used as a delivery vehicle, the nanoparticles themselves can be used as viral therapy, acting to block the viral replication cycle or cell entry. Particles constructed from copper, silver and gold are also capable of generating reactive oxygen species. In addition to being directly damaging to viral genetic material, it can induce apoptosis in infected cells, thus preventing viral propagation.